World Rapid MDKs Market Examined by Industry Experts in New Report Available at MarketPublishers.com

01 Jun 2015 • by Natalie Aster

LONDON – The world’s market for rapid medical diagnostic kits (MDKs) has been seeing stable, albeit not very fast-paced growth over the past several years, with the trend likely to continue in the forthcoming years. One of the major factors fuelling the sector’s expansion is the quick time, typically within a period of 30 minutes, within which test results are usually made available. This helps physicians in speeding up the treatment process for individuals by prescribing the proper medications within a short period of time.

Rapid medical diagnostic kits have also been finding increasing use in home based settings, and especially in the fields of blood glucose testing and/or monitoring and pregnancy testing; and a number of companies are offering convenient to use home-based tests for a slew of purposes. Developing countries of APAC and South America are leading the usage of home-based rapid medical diagnostic kits. Rising disposable income levels in these regions have resulted in rapid changes in lifestyles in the population, which has been invoking the onset of lifestyle related diseases like diabetes.

The global market for rapid MDKs is forecast to grow from USD 19.4 billion in 2014 to USD 20.4 billion in 2015; by 2020, it is expected to expand further, maintaining a CAGR of 5.7% through to 2020 to reach a value of USD 27 billion by the end of the forecast period.

The study highlights the three rapid MDKs application segments which are further broken down into smaller application areas, reviews key rapid MDKs technologies, and tracks the latest market and business trends. It offers profiles of the top 42 global players and 55 dominant players operating in North America, Europe and APAC. A global listing of the 193 companies involved in producing and supply of rapid MDKs is included. Detailed market development forecasts to 2020 can also found in the report.